Cvm pps .26 cents, I wonder if big pharma is paying attention? well big pharma Teva is one of Cvm trial partners and want to be a major player in the oncology market due to recent and upcoming patent expirations. Cvm state of the art facility to manufacture Multikine is up and running.)
Let it be written,
Dr. Tony Montello has backed the truck up at .26
I doubt a spike up from a severe oversold condition has anything to do with something that is only in P2. The move above .26 was a mini short squeeze (really fun watching the tape action today).
Cvm is starting to move up before may 2013, if all patient enrollment is complete and any kinda positive data announcement watch the pps shoot over $5.00 in a hurry.
Sentiment: Strong Buy